

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>New advances in understanding thyroid-associated... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-134/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-134" />
    
            <meta name="description" content="Read the original article in full on F1000Research: New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor" />
    
            <meta name="og:title" content="F1000Research Article: New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor.">
            <meta name="og:description" content="Read the latest article version by Terry J Smith, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="13855">
            <meta name="article-id" content="12787">
            <meta name="dc.title" content="New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor">
            <meta name="dc.description" content="Thyroid-associated ophthalmopathy (TAO), a localized periocular manifestation of the autoimmune syndrome known as Graves&rsquo; disease, remains incompletely understood. Discussions of its pathogenesis are generally focused on the thyrotropin receptor, the proposed role for which is supported by substantial evidence. Considerations of any involvement of the insulin-like growth factor-I receptor (IGF-IR) in the disease are frequently contentious. In this brief, topically focused review, I have attempted to provide a balanced perspective based entirely on experimental results that either favor or refute involvement of IGF-IR in TAO. Discussion in this matter seems particularly timely since the currently available treatments of this disfiguring and potentially sight-threatening disease remain inadequate. Importantly, no medical therapy has thus far received approval from the US Food and Drug Administration. Results from a very recently published clinical trial assessing the safety and efficacy of teprotumumab, an inhibitory human anti&ndash;IGF-IR monoclonal antibody, in active, moderate to severe TAO are extremely encouraging. That double-masked, placebo-controlled study involved 88 patients and revealed unprecedented clinical responses in the improvement of proptosis and clinical activity as well as a favorable safety profile. Should those results prove reproducible in an ongoing phase III trial, therapeutic inhibition of IGF-IR could become the basis for paradigm-shifting treatment of this vexing disease.">
            <meta name="dc.subject" content="opthamology, thyroid, Insulin-like growth factor">
            <meta name="dc.creator" content="Smith, Terry J">
            <meta name="dc.date" content="2018/02/01">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.12787.1">
            <meta name="dc.source" content="F1000Research 2018 7:134">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="opthamology">
            <meta name="prism.keyword" content="thyroid">
            <meta name="prism.keyword" content="Insulin-like growth factor">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/02/01">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="134">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.12787.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-134">
            <meta name="citation_title" content="New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor">
            <meta name="citation_abstract" content="Thyroid-associated ophthalmopathy (TAO), a localized periocular manifestation of the autoimmune syndrome known as Graves&rsquo; disease, remains incompletely understood. Discussions of its pathogenesis are generally focused on the thyrotropin receptor, the proposed role for which is supported by substantial evidence. Considerations of any involvement of the insulin-like growth factor-I receptor (IGF-IR) in the disease are frequently contentious. In this brief, topically focused review, I have attempted to provide a balanced perspective based entirely on experimental results that either favor or refute involvement of IGF-IR in TAO. Discussion in this matter seems particularly timely since the currently available treatments of this disfiguring and potentially sight-threatening disease remain inadequate. Importantly, no medical therapy has thus far received approval from the US Food and Drug Administration. Results from a very recently published clinical trial assessing the safety and efficacy of teprotumumab, an inhibitory human anti&ndash;IGF-IR monoclonal antibody, in active, moderate to severe TAO are extremely encouraging. That double-masked, placebo-controlled study involved 88 patients and revealed unprecedented clinical responses in the improvement of proptosis and clinical activity as well as a favorable safety profile. Should those results prove reproducible in an ongoing phase III trial, therapeutic inhibition of IGF-IR could become the basis for paradigm-shifting treatment of this vexing disease.">
            <meta name="citation_description" content="Thyroid-associated ophthalmopathy (TAO), a localized periocular manifestation of the autoimmune syndrome known as Graves&rsquo; disease, remains incompletely understood. Discussions of its pathogenesis are generally focused on the thyrotropin receptor, the proposed role for which is supported by substantial evidence. Considerations of any involvement of the insulin-like growth factor-I receptor (IGF-IR) in the disease are frequently contentious. In this brief, topically focused review, I have attempted to provide a balanced perspective based entirely on experimental results that either favor or refute involvement of IGF-IR in TAO. Discussion in this matter seems particularly timely since the currently available treatments of this disfiguring and potentially sight-threatening disease remain inadequate. Importantly, no medical therapy has thus far received approval from the US Food and Drug Administration. Results from a very recently published clinical trial assessing the safety and efficacy of teprotumumab, an inhibitory human anti&ndash;IGF-IR monoclonal antibody, in active, moderate to severe TAO are extremely encouraging. That double-masked, placebo-controlled study involved 88 patients and revealed unprecedented clinical responses in the improvement of proptosis and clinical activity as well as a favorable safety profile. Should those results prove reproducible in an ongoing phase III trial, therapeutic inhibition of IGF-IR could become the basis for paradigm-shifting treatment of this vexing disease.">
            <meta name="citation_keywords" content="opthamology, thyroid, Insulin-like growth factor">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Terry J Smith">
            <meta name="citation_author_institution" content="Department of Ophthalmology and Visual Sciences, Kellogg Eye Center and Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48105, USA">
            <meta name="citation_publication_date" content="2018/02/01">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="134">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.12787.1">
            <meta name="citation_firstpage" content="134">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-134/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-134.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=13855 /> <input type=hidden id=articleId name=articleId value=12787 /> <input type=hidden id=xmlUrl value="/articles/7-134/v1/xml"/> <input type=hidden id=xmlFileName value="-7-134-v1.xml"> <input type=hidden id=article_uuid value=9ac31451-8cf3-4ca4-b57b-8901518f8c6e /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.12787.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.12787.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-134"
  },
  "headline": "New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth...",
  "datePublished": "2018-02-01T12:11:41",
  "dateModified": "2018-02-01T12:11:41",
  "author": [
    {
      "@type": "Person",
      "name": "Terry J Smith"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Thyroid-associated ophthalmopathy (TAO), a localized periocular manifestation of the autoimmune syndrome known as Graves&rsquo; disease, remains incompletely understood. Discussions of its pathogenesis are generally focused on the thyrotropin receptor, the proposed role for which is supported by substantial evidence. Considerations of any involvement of the insulin-like growth factor-I receptor (IGF-IR) in the disease are frequently contentious. In this brief, topically focused review, I have attempted to provide a balanced perspective based entirely on experimental results that either favor or refute involvement of IGF-IR in TAO. Discussion in this matter seems particularly timely since the currently available treatments of this disfiguring and potentially sight-threatening disease remain inadequate. Importantly, no medical therapy has thus far received approval from the US Food and Drug Administration. Results from a very recently published clinical trial assessing the safety and efficacy of teprotumumab, an inhibitory human anti&ndash;IGF-IR monoclonal antibody, in active, moderate to severe TAO are extremely encouraging. That double-masked, placebo-controlled study involved 88 patients and revealed unprecedented clinical responses in the improvement of proptosis and clinical activity as well as a favorable safety profile. Should those results prove reproducible in an ongoing phase III trial, therapeutic inhibition of IGF-IR could become the basis for paradigm-shifting treatment of this vexing disease."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-134",
            "name": "New advances in understanding thyroid-associated ophthalmopathy and..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> New advances in understanding thyroid-associated ophthalmopathy and... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=13855 data-id=12787 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12787.1" data-recommended="" data-doi="10.12688/f1000research.12787.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-134/v1/pdf?article_uuid=9ac31451-8cf3-4ca4-b57b-8901518f8c6e" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-12787-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-12787-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-12787-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Smith TJ. New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):134 (<a class=new-orange href="https://doi.org/10.12688/f1000research.12787.1" target=_blank>https://doi.org/10.12688/f1000research.12787.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-12787-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=12787 id=track-article-signin-12787 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12787?target=/articles/7-134">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13855 /> <input name=articleId type=hidden value=12787 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:terrysmi@med.umich.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Terry J Smith</span></a><a href="https://orcid.org/0000-0002-6279-9685" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6279-9685</div></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:terrysmi@med.umich.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Terry J Smith</span></a><a href="http://orcid.org/0000-0002-6279-9685" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6279-9685</div></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 01 Feb 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.12787.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Ophthalmology and Visual Sciences, Kellogg Eye Center and Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48105, USA<br/> <p> <div class=margin-bottom> Terry J Smith <br/> <span>Roles: </span> Writing  Original Draft Preparation, Writing  Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=30198-30447></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=30197-30446></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Thyroid-associated ophthalmopathy (TAO), a localized periocular manifestation of the autoimmune syndrome known as Graves disease, remains incompletely understood. Discussions of its pathogenesis are generally focused on the thyrotropin receptor, the proposed role for which is supported by substantial evidence. Considerations of any involvement of the insulin-like growth factor-I receptor (IGF-IR) in the disease are frequently contentious. In this brief, topically focused review, I have attempted to provide a balanced perspective based entirely on experimental results that either favor or refute involvement of IGF-IR in TAO. Discussion in this matter seems particularly timely since the currently available treatments of this disfiguring and potentially sight-threatening disease remain inadequate. Importantly, no medical therapy has thus far received approval from the US Food and Drug Administration. Results from a very recently published clinical trial assessing the safety and efficacy of teprotumumab, an inhibitory human antiIGF-IR monoclonal antibody, in active, moderate to severe TAO are extremely encouraging. That double-masked, placebo-controlled study involved 88 patients and revealed unprecedented clinical responses in the improvement of proptosis and clinical activity as well as a favorable safety profile. Should those results prove reproducible in an ongoing phase III trial, therapeutic inhibition of IGF-IR could become the basis for paradigm-shifting treatment of this vexing disease. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> opthamology, thyroid, Insulin-like growth factor </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Terry J Smith (<a href="mailto:terrysmi@med.umich.edu">terrysmi@med.umich.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Terry J Smith </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The author holds patents related to the detection of antibody-mediated inflammatory auto-immune disorders (US 6936426), the diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders (US 7998681 and US 8153121), and diagnostic methods related to GD and other autoimmune disorders (US 8178304). No other potential conflict of interest relevant to this article was reported. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This work was supported in part by National Institutes of Health grants EY008976, DK063121, EY11708, and 5UM1AI110557; Center for Vision core grant EY007002 from the National Eye Institute; and an unrestricted grant from Research to Prevent Blindness and by the Bell Charitable Foundation. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2018 Smith TJ. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Smith TJ. New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):134 (<a href="https://doi.org/10.12688/f1000research.12787.1" target=_blank>https://doi.org/10.12688/f1000research.12787.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 01 Feb 2018, <b>7</b>(F1000 Faculty Rev):134 (<a href="https://doi.org/10.12688/f1000research.12787.1" target=_blank>https://doi.org/10.12688/f1000research.12787.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 01 Feb 2018, <b>7</b>(F1000 Faculty Rev):134 (<a href="https://doi.org/10.12688/f1000research.12787.1" target=_blank>https://doi.org/10.12688/f1000research.12787.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d6345e143>Introduction</h2><p class="" id=d6345e146>This brief review is intended to clarify the current understanding of thyroid-associated ophthalmopathy (TAO), its pathogenesis, and how identification of fundamental disease mechanisms might ultimately dictate its treatment. TAO is characterized by inflammation and remodeling of the soft tissues of the orbit and upper face (<a href="#f1">Figure 1</a>)<sup><a href="#ref-1">1</a></sup>. It is a manifestation of Graves disease (GD), a systemic autoimmune syndrome<sup><a href="#ref-2">2</a></sup>. About 40% of patients with GD develop clinically significant TAO<sup><a href="#ref-1">1</a></sup>. Many of those manifesting ocular disease require local supportive therapy. Others with more severe TAO require aggressive therapies such as systemic glucocorticoids and external beam orbital radiation<sup><a href="#ref-3">3</a>,<a href="#ref-4">4</a></sup>. These options come with substantial side effects that limit their dosage and treatment duration. Outcomes of remedial surgeries, usually reserved for patients with the most severe disease, are unpredictable and can reactivate the inflammatory, progressive (active) phase of TAO<sup><a href="#ref-5">5</a></sup>. In GD, the thyroid becomes overactive and produces excessive thyroid hormones, a consequence of the generation of activating antibodies (thyroid-stimulating immunoglobulin, or TSI) targeting the thyrotropin receptor (thyroid-stimulating hormone receptor, or TSHR)<sup><a href="#ref-6">6</a></sup>. The immunological events underlying disease manifestations occurring in the thyroid and orbit in GD are presumed to be closely related if not identical. It is possible that the orbit and thyroid share the expression of an autoantigen (or autoantigens) and that immunoreactivity within the thyroid initiates events occurring in the orbit. This attractive theory has yet to be proven, and many details of disease pathogenesis occurring in both tissues remain uncertain. While hyperthyroidism is treated effectively with decades-old approaches, clinical management of TAO remains largely unsatisfactory and therefore represents an important unmet public health need. None of the existing medical therapies for TAO has achieved registration by the US Food and Drug Administration. Thus, it will be necessary to identify better therapeutic targets for the orbital disease if we are to advance the care of patients with TAO.</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/13855/8fefbd98-85ae-4eb8-92e2-e393c884379e_figure1.gif"><img alt="8fefbd98-85ae-4eb8-92e2-e393c884379e_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/13855/8fefbd98-85ae-4eb8-92e2-e393c884379e_figure1.gif"></a><div class=caption><h3>Figure 1. Facial appearance of a patient with thyroid-associated ophthalmopathy.</h3><p id=d6345e190>In this case, involvement of the tissues surrounding the eye is dramatically asymmetrical. Note the upper eyelid edema, eyelid retraction and the facial redness.</p></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d6345e200>Thyroglobulin as the initially identified orbital autoantigen candidate in thyroid-associated ophthalmopathy</h2><p class="" id=d6345e203>Current understanding of TAO involves a complex set of interactions between the professional immune system and the residential tissues in the orbit (<a href="#f2">Figure 2</a>). A long-held view of the underpinning connection between GD occurring within the thyroid and orbit focuses on the potential for a shared autoantigen. Thyroglobulin (Tg) was the earliest candidate antigen emerging from the work of Kriss<sup><a href="#ref-7">7</a></sup>. His findings suggested that Tg could accumulate in the TAO orbit. He proposed that the protein was transported in GD through the lymphatic system from the thyroid to the orbit. He apparently never considered the potential for localized, ectopic Tg synthesis in orbital connective tissues. His theoretical model for TAO pathogenesis remained unembellished for several decades. Another laboratory group reported that they could not detect Tg in extraocular muscle<sup><a href="#ref-8">8</a></sup>. Much more recently, a group in Italy<sup><a href="#ref-9">9</a>,<a href="#ref-10">10</a></sup> demonstrated the Tg-binding capacity of orbital fibroblasts. That same group detected Tg in orbital fibroadipose tissue from the majority of patients (four out of six) with TAO whom they studied. Furthermore, they could detect thyroxine residues in most of the samples and interpreted that finding as strongly suggestive that orbital Tg was of thyroid origin.</p><div class="fig panel clearfix"><a name=f2 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/13855/8fefbd98-85ae-4eb8-92e2-e393c884379e_figure2.gif"><img alt="8fefbd98-85ae-4eb8-92e2-e393c884379e_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/13855/8fefbd98-85ae-4eb8-92e2-e393c884379e_figure2.gif"></a><div class=caption><h3>Figure 2. Pathogenesis of Graves disease affecting the orbit.</h3><p id=d6345e234>The orbit becomes infiltrated by B and T cells and CD34<sup>+</sup> fibrocytes uniquely in thyroid-associated ophthalmopathy. Bone marrow-derived fibrocytes express several proteins traditionally considered thyroid-specific. They can differentiate into CD34<sup>+</sup> fibroblasts which can further develop into myofibroblasts or adipocytes depending upon the molecular cues they receive from the tissue microenvironment. CD34<sup>+</sup> fibroblasts cohabit the orbit with residential CD34<sup></sup> fibroblasts. These heterogeneous populations of orbital fibroblasts can produce cytokines under basal and activated states. These include interleukin-1beta (IL-1), IL-6, IL-8, IL-10, and IL-16; IL-1 receptor antagonists; tumor necrosis factor-alpha; the chemokine known as regulated on activation, normal T expressed and secreted (or RANTES); CD40 ligand; and several other cytokines and chemokines. These cytokines can act on infiltrating and residential cells. Like fibrocytes, CD34<sup>+</sup> fibroblasts express thyrotropin receptor, thyroglobulin, and other thyroid proteins but at substantially lower levels. Thyroid-stimulating immunoglobulins and potentially other autoantibodies directed specifically at the insulin-like growth factor-I receptor activate the thyrotropin/insulin-like growth factor receptor-I complex, resulting in the activation of several downstream signaling pathways and expression of target genes. Orbital fibroblasts synthesize hyaluronan, leading to increased orbital tissue volume. This expanded tissue can result in proptosis and optic nerve compression. Orbital fat also expands from <i>de novo</i> adipogenesis. IGF-I, insulin-like growth factor I; MHC, major histocompatibility complex; RANTES, regulated on activation, normal T cell expressed and secreted; TGF-, transforming growth factor-beta; TNF-, tumor necrosis factor-alpha. Reprinted with permission from the Massachusetts Medical Society<sup><a href="#ref-2">2</a></sup>. </p></div></div><p class="" id=d6345e264>These concepts concerning how Tg might accumulate in the TAO orbit have been modified substantially following the discovery by Douglas <i>et al</i>. of fibrocytes in the TAO orbit<sup><a href="#ref-11">11</a></sup>. These investigators reported increased abundance of circulating CD34<sup>+</sup> fibrocytes in GD. Fibrocytes derive from the monocyte lineage and appear to play important roles in tissue remodeling and wound healing<sup><a href="#ref-12">12</a></sup>. They have been implicated in TAO where they infiltrate connective tissues of the orbit while retaining their CD34<sup>+</sup>CXCR4<sup>+</sup>Collagen I<sup>+</sup> phenotype. They cohabitate the fibroblast population in the fatty tissues with residential CD34<sup></sup> fibroblasts. Fibrocytes have also been associated with several other autoimmune diseases, including rheumatoid arthritis, scleroderma, diabetes mellitus, and inflammatory bowel disease<sup><a href="#ref-13">13</a><a href="#ref-15">15</a></sup>. Fibrocytes can differentiate into myofibroblasts, adipocytes, osteoblasts, and chondrocytes<sup><a href="#ref-16">16</a></sup>. With regard to TAO, the cells appear to account, at least in part, for the cellular heterogeneity found in the orbit<sup><a href="#ref-11">11</a></sup>. Fibrocytes express several proteins heretofore considered to be thyroid-specific<sup><a href="#ref-17">17</a></sup>. Among these, Tg was found to be synthesized <i>de novo</i> by these cells<sup><a href="#ref-18">18</a></sup>. The molecule appears to be functional in that it can incorporate iodine. These findings thus have provided a plausible explanation for extra-thyroidal production of Tg and its accumulation in orbital connective tissue in TAO<sup><a href="#ref-7">7</a></sup>. Current evidence in aggregate, however, does not support direct involvement of orbital Tg in the pathogenesis of TAO. While anti-Tg antibodies are commonly detected in patients with autoimmune thyroid diseases such as GD, these antibodies appear to be non-pathogenic and are not specific for TAO or GD<sup><a href="#ref-19">19</a></sup>. Furthermore, antigen-specific T cells have not been detected infiltrating orbital tissues in the disease. Clearly, further investigation into the consequences of orbital Tg will need to be undertaken before definitive statements can be made about involvement of this protein in ocular GD.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d6345e332>Thyroid-stimulating hormone receptor as a candidate orbital antigen in thyroid-associated ophthalmopathy</h2><p class="" id=d6345e335>Cloning of the TSHR gene by Parmentier <i>et al</i>.<sup><a href="#ref-20">20</a></sup> ushered in a period of active inquiry into its physiological roles and its participation in human disease. The receptor was detected in thyroid epithelium, as anticipated, but also in several adipose tissue depots, albeit at substantially lower levels. These include normal orbital tissue and fat from patients with TAO<sup><a href="#ref-21">21</a></sup>. These observations led to the now widely held view that TSHR may represent an important link between the thyroid and orbit in GD. Supporting this concept, TSH and immunoglobulin G from patients with GD (GD-IgG) have been shown to exert actions in cultured orbital fibroblasts and fibrocytes<sup><a href="#ref-11">11</a>,<a href="#ref-22">22</a>,<a href="#ref-23">23</a></sup>. The expression of several cytokines can be upregulated as can the accumulation of hyaluronan in orbital fibroblasts<sup><a href="#ref-22">22</a><a href="#ref-24">24</a></sup>. TSIs can be detected in most patients with TAO, and studies have suggested that the levels of these antibodies correlate with disease severity and activity<sup><a href="#ref-25">25</a></sup>. In contrast, a small minority of patients with TAO can present in the euthyroid state with undetectable TSIs<sup><a href="#ref-26">26</a></sup>. These unusual cases, some with severe eye disease, may prove powerfully instructive in that they have called into question the notion that TSIs are absolutely required for the development of TAO. They certainly do raise the possibility that another autoantigen and its cognate antibody play a role in the pathogenesis of the disease.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d6345e378>Thyroid-stimulating hormone receptor immunization in rodent models of Graves disease</h2><p class="" id=d6345e381>Efforts to generate animal models of GD date back decades. Some were successful in generating antibody-driven thyroid dysfunction but most lacked orbital pathology. A recently developed mouse created by transferring human TSHR A-subunit to NOD-<i>H2<sup>h4</sup></i> mice resulted in euthyroid TSHR-transgenic NOD-<i>H2<sup>h4</sup></i> animals spontaneously generating pathogenic anti-human TSHR antibodies and apparently not developing orbital manifestations<sup><a href="#ref-27">27</a></sup>. Female mice were more prone to developing these antibodies than were the male animals. Recent progress has been made in the development of more complete animal models of GD based on immunizations with TSHR. One group reported the induction of periocular changes bearing variable resemblance to the pathology commonly observed in human disease<sup><a href="#ref-28">28</a></sup>. Their model involved animals immunized with human TSHR A-subunit plasmid delivered intramuscularly followed by electroporation. The phenotypes generated with their experimental protocol are variable and diverge from the typical clinical presentation of human GD and TAO. In their first report, 75% of female BALB/c mice developed hyperthyroidism and detectable TSI<sup><a href="#ref-28">28</a></sup>. Thyroids were enlarged and infiltrated with mononuclear cells in a patchy distribution. Orbital tissues exhibited fibrosis and an accumulation of Massons trichrome-staining material. A second report<sup><a href="#ref-29">29</a></sup> using what appears to be an identical experiment protocol resulted in profoundly hypothyroid animals with TSHR-blocking antibodies and extraocular muscle infiltrates accompanied by hyaluronan deposition and orbital fat expansion. In the enclosed micrographs of affected orbital tissues, a robust mononuclear cell infiltrate appears to be involving the optic nerve, a feature strikingly uncharacteristic of TAO. A third report involving examination of TSHR-immunized mice from this same group describes parallel studies conducted in two academic centers in different countries using the same protocol and yielding hyperthyroid animals<sup><a href="#ref-30">30</a></sup>. Furthermore, the orbital pathology revealed fat expansion, fibrosis, and muscle disruption in the absence of mononuclear cell infiltrates. The authors of these studies conclude that the dominance of stimulatory versus blocking antibodies is random. This point of view appears to lack support of experimental evidence, and the results they have reported thus far suggest that these investigators have simply not yet identified the factors underlying their discrepant results. They rationalize the absence of inflammatory infiltrates in their latest study as consistent with a hit and run immune-mediated inflammatory event<sup><a href="#ref-30">30</a></sup>. Another research group, also employing intramuscular DNA immunization followed by electroporation, found that a large fraction of their animals developed elevated thyroxine levels, anti-TSHR antibodies, and goiters<sup><a href="#ref-31">31</a></sup>. Extraocular muscle and adipose tissue volumes were increased. A different approach, one in which splenocytes from TSHR knockout mice immunized with mouse TSHR A-subunit encoding adenovirus were adoptively transferred to athymic nude mice, resulted in anti-TSHR antibodies and macrophage infiltrates in orbital fat and extraocular muscles<sup><a href="#ref-32">32</a></sup>.</p><p class="" id=d6345e427>In aggregate, these reports describe substantial progress in experimentally inducing phenotypes sharing variable similarity with TAO. They are encouraging; however, concerns have been raised regarding whether rodent models can recapitulate human disease with high fidelity<sup><a href="#ref-33">33</a>,<a href="#ref-34">34</a></sup>. Many investigators contend that small rodents may be incapable of adequately approximating human autoimmune disease, the consequence of fundamental differences in immune systems. Small animal preclinical models for TAO could emerge as useful screening tools for therapy development. In any event, well-conceived, properly controlled, and adequately powered therapeutic trials are likely to remain the mainstays for drug candidates as they embark on the road to registration.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d6345e440>Insulin-like growth factor-I receptor as an active participant in thyroid-associated ophthalmopathy</h2><p class="" id=d6345e443>Important gaps in current understanding of disease pathophysiology and incomplete explanations of the clinical behavior of TAO have prompted consideration of unorthodox mechanisms. For instance, it has not been possible to detect TSI in a small fraction of patients with TAO<sup><a href="#ref-26">26</a></sup>, raising questions about the absolute requirement for those antibodies in disease development. Some patients with GD and extremely high levels of TSI develop TAO whereas others with the identical serological profiles do not. Among the candidate molecules currently discussed as potentially involved in the disease is insulin-like growth factor-I receptor (IGF-IR), a widely expressed cell-surface protein found in most tissues and cell types in the human body. Evidence is mounting that IGF-IR not only may play a substantive role in disease development and progression but also may represent an important therapeutic target.</p><p class="" id=d6345e450>A relationship between the IGF-I pathway and the actions of TSH and TSI was initially demonstrated by Ingbar <i>et al</i>.<sup><a href="#ref-35">35</a></sup>. They found that IGF-I could enhance the effects of those agents in thyroid cells in culture. This synergy between TSH and IGF-I has been confirmed in several recent reports<sup><a href="#ref-36">36</a></sup>. IGF-IR is a membrane-bound tyrosine kinase protein<sup><a href="#ref-37">37</a></sup> that serves as the cognate receptor for both IGF-I and IGF-II. IGF-IR has been implicated in several autoimmune diseases, including type I diabetes mellitus, rheumatoid arthritis, and inflammatory bowel disease<sup><a href="#ref-38">38</a></sup>. Its involvement in TAO has been proposed in a two-component theoretical model stemming largely from work performed in our laboratory. First, antiIGF-IR antibodies have been detected in patients with GD<sup><a href="#ref-39">39</a>,<a href="#ref-40">40</a></sup> and are essentially absent in sera from healthy controls. A major remaining uncertainty is whether those antibodies are active in initiating signaling directly through IGF-IR. Pritchard <i>et al</i>. found that GD-IgG could induce genes encoding T-cell chemoattractant cytokines in orbital fibroblasts<sup><a href="#ref-40">40</a>,<a href="#ref-41">41</a></sup>. Those effects were mediated through the Akt/FRAP/mTor/p70<sup>s6k</sup> pathways, were rapamycin-sensitive, and could be blocked by inhibitory antibodies targeting IGF-IR and by transfection of orbital fibroblasts with a dominant negative IGF-IR<sup><a href="#ref-40">40</a>,<a href="#ref-41">41</a></sup>. In another study, GD-IgG was found to induce the synthesis of hyaluronan in orbital fibroblasts but not in fibroblasts from healthy donors<sup><a href="#ref-24">24</a></sup>. Subsequently, TSHR and IGF-IR were found to form a physical and functional signaling complex<sup><a href="#ref-42">42</a></sup>. Specifically, signaling downstream from TSHR leading to the activation of Erk is dependent on IGF-IR activity. Thus, the detection of antiIGF-IR antibodies with apparent receptor-activating effects<sup><a href="#ref-40">40</a></sup> coupled with the interdependence of TSHR/IGF-IR signaling<sup><a href="#ref-42">42</a>,<a href="#ref-43">43</a></sup> provided the necessary rationale for proposing involvement of IGF-IR in TAO. This concept led directly to organizing a therapeutic trial of an inhibitory antiIGF-IR monoclonal antibody in the treatment of active, moderate to severe TAO<sup><a href="#ref-44">44</a></sup>.</p><p class="" id=d6345e524>Subsequent reports came to a variety of conclusions regarding whether IGF-IR might play a role in TAO. Some have confirmed the dependence of TSHR-initiated signaling on IGF-IR activity by using several different methodologies<sup><a href="#ref-45">45</a></sup>. Others have come to different conclusions concerning whether TSHR and IGF-IR act as integrated molecular partners. Moreover, some authors have dismissed the findings of antiIGF-IR antibodies in GD and TAO<sup><a href="#ref-45">45</a>,<a href="#ref-46">46</a></sup>. Their conclusions are based largely on studies using a variety of different experimental models and approaches. Issues such as assay sensitivities, incomplete assessment of treatment duration, and potentially confounding variations in the cellular targets and experimental conditions used, including culture medium content could have led to results and their interpretations differing from those of the initial studies. In general, these authors attribute all of the actions of GD-IgG to the effects of TSIs acting directly on TSHR. No one comments on the parallel findings of Pritchard <i>et al</i>.<sup><a href="#ref-47">47</a></sup> in synovial fibroblasts from patients with rheumatoid arthritis. In those studies, RA-IgG leads to synovial fibroblast activation identical to that in TAO orbital fibroblasts. Those findings cannot be easily attributed to anti-TSHR antibodies such as TSIs. Another laboratory group presented strong evidence supporting the presence of activating antiIGF-IR antibodies in a subset of patients with GD by using an assay involving HEK cells<sup><a href="#ref-48">48</a></sup>. Thus, in my view, considerably more investigation will be necessary before any definitive conclusions can be drawn concerning the nature of IGF-IR involvement in TAO.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d6345e553>Clinical evidence for insulin-like growth factor-I receptor inhibition as therapy for thyroid-associated ophthalmopathy</h2><p class="" id=d6345e556>Initial testing of the central hypothesis that IGF-IR is intimately involved in the pathogenesis of TAO was accomplished recently with the published report by Smith <i>et al</i>.<sup><a href="#ref-44">44</a></sup>. That study marks the completion of the first clinical trial of teprotumumab in patients with active, moderate to severe disease. The results of that study demonstrate unprecedented, profound reduction of <i>both</i> clinical activity score and proptosis, previously achieved only by surgical means. In total, 88 patients were enrolled in the placebo-controlled, double-masked, multinational trial in which the aggregate primary response comprised improvement of at least 2 points on a 7-point clinical activity score and reduction of proptosis of at least 2 mm at 24 weeks following initiation of the therapeutic phase in the study (more severely affected) eye. These improvements occurred in the absence of a similar magnitude of worsening of these parameters in the contralateral (fellow) eye. Secondary end-points included reduction of the clinical activity score of at least 2 points, reduction of proptosis of at least 2 mm (both measured as continuous variables), improvement in quality of life, and improvement in diplopia. The study design included a 24-week treatment period during which all participants received infusions of either placebo or active drug at 3-week intervals. The effects of the study drug were rapid, and many patients in the treatment group achieved primary end-point response within 6 weeks of their initial infusion. The safety profile was encouraging. The only side effect that could be unambiguously attributed to the drug was hyperglycemia, particularly in those patients with pre-existent diabetes mellitus. Glycemic control was easily restored with adjustment of the diabetes medications. Furthermore, carbohydrate intolerance in those individuals returned to baseline following the end of the treatment phase. Thus, it would appear that an inhibitory antiIGF-IR antibody such as teprotumumab might play an important role in the therapy of active TAO. The findings of the trial suggest that the proposed mechanisms for antiIGF-IR antibody activation of the TSHR/IGF-IR complex, coupled with the attenuation of signaling by teprotumumab, might at least in part underlie disease development. Interrupting this process might also interfere with disease progression and perhaps allow a resetting of the immune clock. This seems plausible in view of the reduction in proptosis observed in the recently concluded trial. Additional studies, conducted <i>in vivo</i>, <i>in vitro</i>, and potentially with experimental animal models, will be necessary to fully determine both disease mechanism and how teprotumumab is effecting its therapeutic benefit. Further inquiry will also be required to gain insight into the anatomic localization of drug action within the orbit. It remains unclear whether teprotumumab might be effective in stable disease. The remarkably rapid reduction in proptosis suggests that well-established disease might also be amenable to the drugs beneficial effects. Based on the results of the trial, the US Food and Drug Administration designated teprotumumab with breakthrough status. The study outcome underscores the importance of conducting placebo-controlled trials in TAO and other relatively rare diseases. These are most likely to yield unambiguous results.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d6345e578>Is B-cell depletion likely to reliably treat thyroid-associated ophthalmopathy?</h2><p class="" id=d6345e581>Two recent small clinical studies investigated the effectiveness of anti-CD20 in active, moderate to severe TAO. The report by Stan <i>et al</i>.<sup><a href="#ref-49">49</a></sup> described a comparison between rituximab and placebo which failed to demonstrate improvement in clinical activity score or proptosis attributable to the drug. The other, by Salvi <i>et al</i>.<sup><a href="#ref-50">50</a></sup>, found that rituximab was more effective than intravenous methylprednisolone in reducing clinical activity score but without clinically meaningful improvement in proptosis.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d6345e601>Other treatment approaches with biological agents</h2><p class="" id=d6345e604>With regard to the numerous biological agents already available and in wide use in other autoimmune diseases, interest has been generated to repurpose some for use in TAO. Initial experience with anti-tumor necrosis factor-alpha (anti-TNF-) has generally proven discouraging, although the studies thus far conducted have been inadequately powered to draw firm conclusions. Tocilizumab, an interleukin-6 (IL-6) receptor antagonist, was examined in a single uncontrolled, prospective study involving 18 patients with TAO<sup><a href="#ref-51">51</a></sup>. The study suggests that the drug might prove effective in active disease, but its design makes any interpretation of the findings difficult. A well-controlled follow-up study might help clarify whether interruption of the IL-6 pathway is likely to yield clinical benefit. Certainly, ample evidence generated <i>in vitro</i> suggests that targeting this cytokine pathway might be a productive avenue to pursue.</p><p class="" id=d6345e614>Another potentially productive approach to therapy of active TAO involves interrupting the TSHR pathway. Two strategies have thus far been pursued. Several TSHR antagonizing monoclonal antibodies have been described<sup><a href="#ref-52">52</a><a href="#ref-54">54</a></sup>. Other laboratory investigators have developed small-molecule TSHR antagonists, including reverse agonists<sup><a href="#ref-55">55</a><a href="#ref-57">57</a></sup>. To my knowledge, none of these agents has reached the stage of clinical trials.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d6345e634>Conclusions</h2><p class="" id=d6345e637>Progress in understanding TAO over the past few years has yielded important detail concerning its relationship with GD occurring within the thyroid gland. This includes the apparent central importance of TSHR and TSI in development of both hyperthyroidism and ocular manifestations of the disease. Many questions remain unanswered. Among the most contentiously discussed is the involvement of IGF-IR in TAO. Widespread general agreement appears to exist that both physical and functional relationships exist between TSHR and IGF-IR<sup><a href="#ref-42">42</a></sup> and some but not all aspects of these have been confirmed by other laboratory groups<sup><a href="#ref-45">45</a></sup>. Whether antiIGF-IR antibodies develop in GD and how they might be involved in activating the receptor remain less well accepted. Emphatic declarations as to whether they exist and what their biological importance might be appear, in my view, to be wildly premature and potentially misleading. Some preliminary findings suggest that, besides IGF-IR, other therapeutic targets, including B-cell depletion, disrupting cytokine pathways, and interrupting TSHR signaling, will require careful consideration. Considerably more research will be required to fully assess the potential therapeutic landscape for TAO. Ultimately, strategies for promoting immune re-tolerization seem most promising since, in theory, they would spare patients the unpleasant prospects of long-term immunosuppression.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d6345e651>Consent</h2><p class="" id=d6345e654>The author thanks the patient whose image appears in <a href="#f1">Figure 1</a> for permission to publish. Written informed consent was obtained from the patient for the use of this image.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d6345e1 class=n-a></a><h2 class=main-title id=d6531>Competing interests</h2><p class=metadata-entry><a name=d6345e74 class=n-a></a><p id=d6345e75> The author holds patents related to the detection of antibody-mediated inflammatory auto-immune disorders (US 6936426), the diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders (US 7998681 and US 8153121), and diagnostic methods related to GD and other autoimmune disorders (US 8178304). No other potential conflict of interest relevant to this article was reported.</p></p></div><div class=back-section><a name=d6345e1 class=n-a></a><h2 class=main-title id=d6533>Grant information</h2><p>This work was supported in part by National Institutes of Health grants EY008976, DK063121, EY11708, and 5UM1AI110557; Center for Vision core grant EY007002 from the National Eye Institute; and an unrestricted grant from Research to Prevent Blindness and by the Bell Charitable Foundation.</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript</i>.</p></div><div class=back-section><a name=d6345e664 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d6735>References</h2><div class="section ref-list"><a name=d6345e664 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d6345e671 class=n-a></a>Wang Y, Smith TJ: Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. <i>Invest Ophthalmol Vis Sci.</i> 2014; <b>55</b>(3): 173548. <a target=xrefwindow id=d6345e679 href="http://www.ncbi.nlm.nih.gov/pubmed/24651704">PubMed Abstract </a> | <a target=xrefwindow id=d6345e682 href="http://dx.doi.org/10.1167/iovs.14-14002">Publisher Full Text </a> | <a target=xrefwindow id=d6345e685 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3968932">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727207631"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6345e694 class=n-a></a>Smith TJ, Hegeds L: Graves' Disease. <i>N Engl J Med.</i> 2016; <b>375</b>(16): 155265. <a target=xrefwindow id=d6345e702 href="http://www.ncbi.nlm.nih.gov/pubmed/27797318">PubMed Abstract </a> | <a target=xrefwindow id=d6345e705 href="http://dx.doi.org/10.1056/NEJMra1510030">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727207631">F1000 Recommendation</a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717961927"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6345e718 class=n-a></a>Bartalena L, Krassas GE, Wiersinga W, <i> et al.</i>: Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy. <i>J Clin Endocrinol Metab.</i> 2012; <b>97</b>(12): 445463. <a target=xrefwindow id=d6345e729 href="http://www.ncbi.nlm.nih.gov/pubmed/23038682">PubMed Abstract </a> | <a target=xrefwindow id=d6345e732 href="http://dx.doi.org/10.1210/jc.2012-2389">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717961927">F1000 Recommendation</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d6345e745 class=n-a></a>Marcocci C, Bartalena L, Tanda ML, <i> et al.</i>: Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. <i>J Clin Endocrinol Metab.</i> 2001; <b>86</b>(8): 35627. <a target=xrefwindow id=d6345e756 href="http://www.ncbi.nlm.nih.gov/pubmed/11502779">PubMed Abstract </a> | <a target=xrefwindow id=d6345e759 href="http://dx.doi.org/10.1210/jcem.86.8.7737">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d6345e768 class=n-a></a>Baldeschi L, Lupetti A, Vu P, <i> et al.</i>: Reactivation of Graves' orbitopathy after rehabilitative orbital decompression. <i>Ophthalmology.</i> 2007; <b>114</b>(7): 1395402. <a target=xrefwindow id=d6345e779 href="http://www.ncbi.nlm.nih.gov/pubmed/17320178">PubMed Abstract </a> | <a target=xrefwindow id=d6345e782 href="http://dx.doi.org/10.1016/j.ophtha.2006.10.036">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d6345e792 class=n-a></a>Michalek K, Morshed SA, Latif R, <i> et al.</i>: TSH receptor autoantibodies. <i>Autoimmun Rev.</i> 2009; <b>9</b>(2): 1136. <a target=xrefwindow id=d6345e803 href="http://www.ncbi.nlm.nih.gov/pubmed/19332151">PubMed Abstract </a> | <a target=xrefwindow id=d6345e806 href="http://dx.doi.org/10.1016/j.autrev.2009.03.012">Publisher Full Text </a> | <a target=xrefwindow id=d6345e810 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3753030">Free Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d6345e819 class=n-a></a>Kriss JP: Radioisotopic thyroidolymphography in patients with Graves' disease. <i>J Clin Endocrinol Metab.</i> 1970; <b>31</b>(3): 31523. <a target=xrefwindow id=d6345e827 href="http://www.ncbi.nlm.nih.gov/pubmed/4916540">PubMed Abstract </a> | <a target=xrefwindow id=d6345e830 href="http://dx.doi.org/10.1210/jcem-31-3-315">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d6345e839 class=n-a></a>Kodama K, Sikorska H, Bayly R, <i> et al.</i>: Use of monoclonal antibodies to investigate a possible role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy. <i>J Clin Endocrinol Metab.</i> 1984; <b>59</b>(1): 6773. <a target=xrefwindow id=d6345e850 href="http://www.ncbi.nlm.nih.gov/pubmed/6327760">PubMed Abstract </a> | <a target=xrefwindow id=d6345e853 href="http://dx.doi.org/10.1210/jcem-59-1-67">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d6345e862 class=n-a></a>Lisi S, Marin M, Pinchera A, <i> et al.</i>: Thyroglobulin in orbital tissues from patients with thyroid-associated ophthalmopathy: predominant localization in fibroadipose tissue. <i>Thyroid.</i> 2002; <b>12</b>(5): 35160. <a target=xrefwindow id=d6345e873 href="http://www.ncbi.nlm.nih.gov/pubmed/12097194">PubMed Abstract </a> | <a target=xrefwindow id=d6345e876 href="http://dx.doi.org/10.1089/105072502760043413">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d6345e885 class=n-a></a>Marin M, Lisi S, Pinchera A, <i> et al.</i>: Glycosaminoglycans provide a binding site for thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy. <i>Thyroid.</i> 2003; <b>13</b>(9): 8519. <a target=xrefwindow id=d6345e896 href="http://www.ncbi.nlm.nih.gov/pubmed/14588099">PubMed Abstract </a> | <a target=xrefwindow id=d6345e899 href="http://dx.doi.org/10.1089/105072503322401041">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d6345e908 class=n-a></a>Douglas RS, Afifiyan NF, Hwang CJ, <i> et al.</i>: Increased generation of fibrocytes in thyroid-associated ophthalmopathy. <i>J Clin Endocrinol Metab.</i> 2010; <b>95</b>(1): 4308. <a target=xrefwindow id=d6345e919 href="http://www.ncbi.nlm.nih.gov/pubmed/19897675">PubMed Abstract </a> | <a target=xrefwindow id=d6345e922 href="http://dx.doi.org/10.1210/jc.2009-1614">Publisher Full Text </a> | <a target=xrefwindow id=d6345e926 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2805489">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d6345e936 class=n-a></a>Bucala R, Spiegel LA, Chesney J, <i> et al.</i>: Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. <i>Mol Med.</i> 1994; <b>1</b>(1): 7181. <a target=xrefwindow id=d6345e947 href="http://www.ncbi.nlm.nih.gov/pubmed/8790603">PubMed Abstract </a> | <a target=xrefwindow id=d6345e950 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2229929">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d6345e959 class=n-a></a>Galligan CL, Siminovitch KA, Keystone EC, <i> et al.</i>: Fibrocyte activation in rheumatoid arthritis. <i>Rheumatology (Oxford).</i> 2010; <b>49</b>(4): 64051. <a target=xrefwindow id=d6345e970 href="http://www.ncbi.nlm.nih.gov/pubmed/19858121">PubMed Abstract </a> | <a target=xrefwindow id=d6345e973 href="http://dx.doi.org/10.1093/rheumatology/kep265">Publisher Full Text </a> | <a target=xrefwindow id=d6345e977 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2909797">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d6345e986 class=n-a></a>Kanasaki K, Taduri G, Koya D: Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis. <i>Front Endocrinol (Lausanne).</i> 2013; <b>4</b>: 7. <a target=xrefwindow id=d6345e994 href="http://www.ncbi.nlm.nih.gov/pubmed/23390421">PubMed Abstract </a> | <a target=xrefwindow id=d6345e997 href="http://dx.doi.org/10.3389/fendo.2013.00007">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1000 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3565176">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d6345e1009 class=n-a></a>Sazuka S, Katsuno T, Nakagawa T, <i> et al.</i>: Fibrocytes are involved in inflammation as well as fibrosis in the pathogenesis of Crohn's disease. <i>Dig Dis Sci.</i> 2014; <b>59</b>(4): 7608. <a target=xrefwindow id=d6345e1020 href="http://www.ncbi.nlm.nih.gov/pubmed/23975339">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1023 href="http://dx.doi.org/10.1007/s10620-013-2813-8">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d6345e1032 class=n-a></a>Hong KM, Belperio JA, Keane MP, <i> et al.</i>: Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. <i>J Biol Chem.</i> 2007; <b>282</b>(31): 2291020. <a target=xrefwindow id=d6345e1043 href="http://www.ncbi.nlm.nih.gov/pubmed/17556364">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1046 href="http://dx.doi.org/10.1074/jbc.M703597200">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d6345e1055 class=n-a></a>Fernando R, Lu Y, Atkins SJ, <i> et al.</i>: Expression of thyrotropin receptor, thyroglobulin, sodium-iodide symporter, and thyroperoxidase by fibrocytes depends on AIRE. <i>J Clin Endocrinol Metab.</i> 2014; <b>99</b>(7): E123644. <a target=xrefwindow id=d6345e1066 href="http://www.ncbi.nlm.nih.gov/pubmed/24708100">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1069 href="http://dx.doi.org/10.1210/jc.2013-4271">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1073 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4079309">Free Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d6345e1083 class=n-a></a>Fernando R, Atkins S, Raychaudhuri N, <i> et al.</i>: Human fibrocytes coexpress thyroglobulin and thyrotropin receptor. <i>Proc Natl Acad Sci U S A.</i> 2012; <b>109</b>(19): 742732. <a target=xrefwindow id=d6345e1094 href="http://www.ncbi.nlm.nih.gov/pubmed/22517745">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1097 href="http://dx.doi.org/10.1073/pnas.1202064109">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1101 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3358913">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727650851"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6345e1110 class=n-a></a>Frhlich E, Wahl R: Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases. <i>Front Immunol.</i> 2017; <b>8</b>: 521. <a target=xrefwindow id=d6345e1118 href="http://www.ncbi.nlm.nih.gov/pubmed/28536577">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1121 href="http://dx.doi.org/10.3389/fimmu.2017.00521">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1124 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5422478">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727650851">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d6345e1137 class=n-a></a>Parmentier M, Libert F, Maenhaut C, <i> et al.</i>: Molecular cloning of the thyrotropin receptor. <i>Science.</i> 1989; <b>246</b>(4937): 16202. <a target=xrefwindow id=d6345e1148 href="http://www.ncbi.nlm.nih.gov/pubmed/2556796">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1151 href="http://dx.doi.org/10.1126/science.2556796">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d6345e1160 class=n-a></a>Feliciello A, Porcellini A, Ciullo I, <i> et al.</i>: Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. <i>Lancet.</i> 1993; <b>342</b>(8867): 3378. <a target=xrefwindow id=d6345e1171 href="http://www.ncbi.nlm.nih.gov/pubmed/8101586">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1174 href="http://dx.doi.org/10.1016/0140-6736(93)91475-2">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d6345e1183 class=n-a></a>Raychaudhuri N, Fernando R, Smith TJ: Thyrotropin regulates IL-6 expression in CD34<sup>+</sup> fibrocytes: clear delineation of its cAMP-independent actions. <i>PLoS One.</i> 2013; <b>8</b>(9): e75100. <a target=xrefwindow id=d6345e1194 href="http://www.ncbi.nlm.nih.gov/pubmed/24086448">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1197 href="http://dx.doi.org/10.1371/journal.pone.0075100">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1201 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3783445">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d6345e1210 class=n-a></a>Kumar S, Schiefer R, Coenen MJ, <i> et al.</i>: A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves' orbital preadipocyte fibroblasts. <i>Thyroid.</i> 2010; <b>20</b>(1): 5965. <a target=xrefwindow id=d6345e1221 href="http://www.ncbi.nlm.nih.gov/pubmed/20017620">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1224 href="http://dx.doi.org/10.1089/thy.2009.0278">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1228 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2833174">Free Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d6345e1238 class=n-a></a>Smith TJ, Hoa N: Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor. <i>J Clin Endocrinol Metab.</i> 2004; <b>89</b>(10): 507680. <a target=xrefwindow id=d6345e1246 href="http://www.ncbi.nlm.nih.gov/pubmed/15472208">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1249 href="http://dx.doi.org/10.1210/jc.2004-0716">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732540527"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6345e1258 class=n-a></a>Woo YJ, Jang SY, Lim TH, <i> et al.</i>: Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy. <i>Korean J Ophthalmol.</i> 2015; <b>29</b>(4): 2139. <a target=xrefwindow id=d6345e1269 href="http://www.ncbi.nlm.nih.gov/pubmed/26240504">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1272 href="http://dx.doi.org/10.3341/kjo.2015.29.4.213">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1276 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4520863">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732540527">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732540528"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6345e1289 class=n-a></a>Tabasum A, Khan I, Taylor P, <i> et al.</i>: Thyroid antibody-negative euthyroid Graves' ophthalmopathy. <i>Endocrinol Diabetes Metab Case Rep.</i> 2016; <b>2016</b>: 160008. <a target=xrefwindow id=d6345e1300 href="http://www.ncbi.nlm.nih.gov/pubmed/27284451">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1303 href="http://dx.doi.org/10.1530/EDM-16-0008">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1307 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4898069">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732540528">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725413190"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6345e1320 class=n-a></a>Rapoport B, Aliesky HA, Banuelos B, <i> et al.</i>: A unique mouse strain that develops spontaneous, iodine-accelerated, pathogenic antibodies to the human thyrotrophin receptor. <i>J Immunol.</i> 2015; <b>194</b>(9): 415461. <a target=xrefwindow id=d6345e1331 href="http://www.ncbi.nlm.nih.gov/pubmed/25825442">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1334 href="http://dx.doi.org/10.4049/jimmunol.1500126">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1338 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4402262">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725413190">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d6345e1351 class=n-a></a>Zhao SX, Tsui S, Cheung A, <i> et al.</i>: Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA. <i>J Endocrinol.</i> 2011; <b>210</b>(3): 36977. <a target=xrefwindow id=d6345e1362 href="http://www.ncbi.nlm.nih.gov/pubmed/21715431">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1365 href="http://dx.doi.org/10.1530/JOE-11-0162">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1369 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3152291">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718052713"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6345e1378 class=n-a></a>Moshkelgosha S, So PW, Deasy N, <i> et al.</i>: Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-<i>in vivo</i> electroporation. <i>Endocrinology.</i> 2013; <b>154</b>(9): 300815. <a target=xrefwindow id=d6345e1392 href="http://www.ncbi.nlm.nih.gov/pubmed/23900776">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1396 href="http://dx.doi.org/10.1210/en.2013-1576">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718052713">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726142064"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6345e1410 class=n-a></a>Berchner-Pfannschmidt U, Moshkelgosha S, Diaz-Cano S, <i> et al.</i>: Comparative Assessment of Female Mouse Model of Graves' Orbitopathy Under Different Environments, Accompanied by Proinflammatory Cytokine and T-Cell Responses to Thyrotropin Hormone Receptor Antigen. <i>Endocrinology.</i> 2016; <b>157</b>(4): 167382. <a target=xrefwindow id=d6345e1421 href="http://www.ncbi.nlm.nih.gov/pubmed/26872090">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1424 href="http://dx.doi.org/10.1210/en.2015-1829">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726142064">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727423050"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6345e1437 class=n-a></a>Xia N, Ye X, Hu X, <i> et al.</i>: Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice. <i>PLoS One.</i> 2017; <b>12</b>(3): e0174260. <a target=xrefwindow id=d6345e1448 href="http://www.ncbi.nlm.nih.gov/pubmed/28319174">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1451 href="http://dx.doi.org/10.1371/journal.pone.0174260">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1455 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5358867">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727423050">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d6345e1468 class=n-a></a>Nakahara M, Johnson K, Eckstein A, <i> et al.</i>: Adoptive transfer of antithyrotropin receptor (TSHR) autoimmunity from TSHR knockout mice to athymic nude mice. <i>Endocrinology.</i> 2012; <b>153</b>(4): 203442. <a target=xrefwindow id=d6345e1479 href="http://www.ncbi.nlm.nih.gov/pubmed/22334716">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1482 href="http://dx.doi.org/10.1210/en.2011-1846">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717978462"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6345e1491 class=n-a></a>Seok J, Warren HS, Cuenca AG, <i> et al.</i>: Genomic responses in mouse models poorly mimic human inflammatory diseases. <i>Proc Natl Acad Sci U S A.</i> 2013; <b>110</b>(9): 350712. <a target=xrefwindow id=d6345e1502 href="http://www.ncbi.nlm.nih.gov/pubmed/23401516">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1505 href="http://dx.doi.org/10.1073/pnas.1222878110">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1509 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3587220">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717978462">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d6345e1522 class=n-a></a>Takao K, Miyakawa T: Genomic responses in mouse models greatly mimic human inflammatory diseases. <i>Proc Natl Acad Sci U S A.</i> 2015; <b>112</b>(4): 116772. <a target=xrefwindow id=d6345e1530 href="http://www.ncbi.nlm.nih.gov/pubmed/25092317">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1533 href="http://dx.doi.org/10.1073/pnas.1401965111">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1536 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4313832">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d6345e1545 class=n-a></a>Tramontano D, Cushing GW, Moses AC, <i> et al.</i>: Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves'-IgG. <i>Endocrinology.</i> 1986; <b>119</b>(2): 9402. <a target=xrefwindow id=d6345e1556 href="http://www.ncbi.nlm.nih.gov/pubmed/2874015">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1559 href="http://dx.doi.org/10.1210/endo-119-2-940">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731737249"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6345e1569 class=n-a></a>Krieger CC, Perry JD, Morgan SJ, <i> et al.</i>: TSH/IGF-1 Receptor Cross-Talk Rapidly Activates Extracellular Signal-Regulated Kinases in Multiple Cell Types. <i>Endocrinology.</i> 2017; <b>158</b>(10): 367683. <a target=xrefwindow id=d6345e1580 href="http://www.ncbi.nlm.nih.gov/pubmed/28938449">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1583 href="http://dx.doi.org/10.1210/en.2017-00528">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1587 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5659693">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731737249">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d6345e1600 class=n-a></a>Gallagher EJ, LeRoith D: Minireview: IGF, Insulin, and Cancer. <i>Endocrinology.</i> 2011; <b>152</b>(7): 254651. <a target=xrefwindow id=d6345e1608 href="http://www.ncbi.nlm.nih.gov/pubmed/21540285">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1611 href="http://dx.doi.org/10.1210/en.2011-0231">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d6345e1620 class=n-a></a>Smith TJ: Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases? <i>Pharmacol Rev.</i> 2010; <b>62</b>(2): 199236. <a target=xrefwindow id=d6345e1628 href="http://www.ncbi.nlm.nih.gov/pubmed/20392809">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1631 href="http://dx.doi.org/10.1124/pr.109.002469">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1634 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2879913">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d6345e1643 class=n-a></a>Weightman DR, Perros P, Sherif IH, <i> et al.</i>: Autoantibodies to IGF-1 binding sites in thyroid associated ophthalmopathy. <i>Autoimmunity.</i> 1993; <b>16</b>(4): 2517. <a target=xrefwindow id=d6345e1654 href="http://www.ncbi.nlm.nih.gov/pubmed/7517705">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1657 href="http://dx.doi.org/10.3109/08916939309014643">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d6345e1666 class=n-a></a>Pritchard J, Han R, Horst N, <i> et al.</i>: Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway. <i>J Immunol.</i> 2003; <b>170</b>(12): 634854. <a target=xrefwindow id=d6345e1677 href="http://www.ncbi.nlm.nih.gov/pubmed/12794168">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1680 href="http://dx.doi.org/10.4049/jimmunol.170.12.6348">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d6345e1689 class=n-a></a>Pritchard J, Horst N, Cruikshank W, <i> et al.</i>: Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts. <i>J Immunol.</i> 2002; <b>168</b>(2): 94250. <a target=xrefwindow id=d6345e1700 href="http://www.ncbi.nlm.nih.gov/pubmed/11777993">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1703 href="http://dx.doi.org/10.4049/jimmunol.168.2.942">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d6345e1713 class=n-a></a>Tsui S, Naik V, Hoa N, <i> et al.</i>: Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease. <i>J Immunol.</i> 2008; <b>181</b>(6): 4397405. <a target=xrefwindow id=d6345e1724 href="http://www.ncbi.nlm.nih.gov/pubmed/18768899">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1727 href="http://dx.doi.org/10.4049/jimmunol.181.6.4397">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1731 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2775538">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d6345e1740 class=n-a></a>Chen H, Mester T, Raychaudhuri N, <i> et al.</i>: Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes. <i>J Clin Endocrinol Metab.</i> 2014; <b>99</b>(9): E163540. <a target=xrefwindow id=d6345e1751 href="http://www.ncbi.nlm.nih.gov/pubmed/24878056">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1754 href="http://dx.doi.org/10.1210/jc.2014-1580">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1758 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4154099">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727577398"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6345e1767 class=n-a></a>Smith TJ, Kahaly GJ, Ezra DG, <i> et al.</i>: Teprotumumab for Thyroid-Associated Ophthalmopathy. <i>N Engl J Med.</i> 2017; <b>376</b>(18): 174861. <a target=xrefwindow id=d6345e1778 href="http://www.ncbi.nlm.nih.gov/pubmed/28467880">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1781 href="http://dx.doi.org/10.1056/NEJMoa1614949">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1785 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5718164">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727577398">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726263936"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6345e1798 class=n-a></a>Krieger CC, Place RF, Bevilacqua C, <i> et al.</i>: TSH/IGF-1 Receptor Cross Talk in Graves' Ophthalmopathy Pathogenesis. <i>J Clin Endocrinol Metab.</i> 2016; <b>101</b>(6): 23407. <a target=xrefwindow id=d6345e1809 href="http://www.ncbi.nlm.nih.gov/pubmed/27043163">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1812 href="http://dx.doi.org/10.1210/jc.2016-1315">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1816 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4891793">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726263936">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d6345e1829 class=n-a></a>Minich WB, Dehina N, Welsink T, <i> et al.</i>: Autoantibodies to the IGF1 receptor in Graves' orbitopathy. <i>J Clin Endocrinol Metab.</i> 2013; <b>98</b>(2): 75260. <a target=xrefwindow id=d6345e1840 href="http://www.ncbi.nlm.nih.gov/pubmed/23264397">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1843 href="http://dx.doi.org/10.1210/jc.2012-1771">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d6345e1852 class=n-a></a>Pritchard J, Tsui S, Horst N, <i> et al.</i>: Synovial fibroblasts from patients with rheumatoid arthritis, like fibroblasts from Graves' disease, express high levels of IL-16 when treated with Igs against insulin-like growth factor-1 receptor. <i>J Immunol.</i> 2004; <b>173</b>(5): 35649. <a target=xrefwindow id=d6345e1863 href="http://www.ncbi.nlm.nih.gov/pubmed/15322222">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1866 href="http://dx.doi.org/10.4049/jimmunol.173.5.3564">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d6345e1876 class=n-a></a>Varewijck AJ, Boelen A, Lamberts SW, <i> et al.</i>: Circulating IgGs may modulate IGF-I receptor stimulating activity in a subset of patients with Graves' ophthalmopathy. <i>J Clin Endocrinol Metab.</i> 2013; <b>98</b>(2): 76976. <a target=xrefwindow id=d6345e1887 href="http://www.ncbi.nlm.nih.gov/pubmed/23295466">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1890 href="http://dx.doi.org/10.1210/jc.2012-2270">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/723891046"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6345e1899 class=n-a></a>Stan MN, Garrity JA, Carranza Leon BG, <i> et al.</i>: Randomized controlled trial of rituximab in patients with Graves' orbitopathy. <i>J Clin Endocrinol Metab.</i> 2015; <b>100</b>(2): 43241. <a target=xrefwindow id=d6345e1910 href="http://www.ncbi.nlm.nih.gov/pubmed/25343233">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1913 href="http://dx.doi.org/10.1210/jc.2014-2572">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1917 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4318907">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/723891046">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725276554"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6345e1930 class=n-a></a>Salvi M, Vannucchi G, Curr N, <i> et al.</i>: Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study. <i>J Clin Endocrinol Metab.</i> 2015; <b>100</b>(2): 42231. <a target=xrefwindow id=d6345e1941 href="http://www.ncbi.nlm.nih.gov/pubmed/25494967">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1944 href="http://dx.doi.org/10.1210/jc.2014-3014">Publisher Full Text </a> | <a target=xrefwindow id=d6345e1948 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4318899">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725276554">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718269210"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d6345e1961 class=n-a></a>Prez-Moreiras JV, Alvarez-Lpez A, Gmez EC: Treatment of active corticosteroid-resistant graves' orbitopathy. <i>Ophthal Plast Reconstr Surg.</i> 2014; <b>30</b>(2): 1627. <a target=xrefwindow id=d6345e1969 href="http://www.ncbi.nlm.nih.gov/pubmed/24503568">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1972 href="http://dx.doi.org/10.1097/IOP.0000000000000037">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718269210">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d6345e1985 class=n-a></a>Sanders J, Allen F, Jeffreys J, <i> et al.</i>: Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist. <i>Thyroid.</i> 2005; <b>15</b>(7): 67282. <a target=xrefwindow id=d6345e1996 href="http://www.ncbi.nlm.nih.gov/pubmed/16053383">PubMed Abstract </a> | <a target=xrefwindow id=d6345e1999 href="http://dx.doi.org/10.1089/thy.2005.15.672">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d6345e2008 class=n-a></a>Chen C, McLachlan SM, Rapoport B: A monoclonal antibody with thyrotropin (TSH) receptor inverse agonist and TSH antagonist activities binds to the receptor hinge region as well as to the leucine-rich domain. <i>Endocrinology.</i> 2009; <b>150</b>(7): 34018. <a target=xrefwindow id=d6345e2016 href="http://www.ncbi.nlm.nih.gov/pubmed/19299457">PubMed Abstract </a> | <a target=xrefwindow id=d6345e2019 href="http://dx.doi.org/10.1210/en.2008-1800">Publisher Full Text </a> | <a target=xrefwindow id=d6345e2022 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2703505">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d6345e2032 class=n-a></a>Sanders P, Young S, Sanders J, <i> et al.</i>: Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody. <i>J Mol Endocrinol.</i> 2011; <b>46</b>(2): 8199. <a target=xrefwindow id=d6345e2043 href="http://www.ncbi.nlm.nih.gov/pubmed/21247981">PubMed Abstract </a> | <a target=xrefwindow id=d6345e2046 href="http://dx.doi.org/10.1530/JME-10-0127">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d6345e2055 class=n-a></a>Neumann S, Eliseeva E, McCoy JG, <i> et al.</i>: A new small-molecule antagonist inhibits Graves' disease antibody activation of the TSH receptor. <i>J Clin Endocrinol Metab.</i> 2011; <b>96</b>(2): 54854. <a target=xrefwindow id=d6345e2066 href="http://www.ncbi.nlm.nih.gov/pubmed/21123444">PubMed Abstract </a> | <a target=xrefwindow id=d6345e2069 href="http://dx.doi.org/10.1210/jc.2010-1935">Publisher Full Text </a> | <a target=xrefwindow id=d6345e2073 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3048317">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d6345e2082 class=n-a></a>Neumann S, Nir EA, Eliseeva E, <i> et al.</i>: A selective TSH receptor antagonist inhibits stimulation of thyroid function in female mice. <i>Endocrinology.</i> 2014; <b>155</b>(1): 3104. <a target=xrefwindow id=d6345e2093 href="http://www.ncbi.nlm.nih.gov/pubmed/24169564">PubMed Abstract </a> | <a target=xrefwindow id=d6345e2096 href="http://dx.doi.org/10.1210/en.2013-1835">Publisher Full Text </a> | <a target=xrefwindow id=d6345e2100 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3868809">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d6345e2109 class=n-a></a>Jschke H, Neumann S, Moore S, <i> et al.</i>: A low molecular weight agonist signals by binding to the transmembrane domain of thyroid-stimulating hormone receptor (TSHR) and luteinizing hormone/chorionic gonadotropin receptor (LHCGR). <i>J Biol Chem.</i> 2006; <b>281</b>(15): 98414. <a target=xrefwindow id=d6345e2120 href="http://www.ncbi.nlm.nih.gov/pubmed/16488885">PubMed Abstract </a> | <a target=xrefwindow id=d6345e2123 href="http://dx.doi.org/10.1074/jbc.C600014200">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 01 Feb 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-134&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-134&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Ophthalmology and Visual Sciences, Kellogg Eye Center and Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48105, USA<br/> <p> <div class=margin-bottom> Terry J Smith <br/> <span>Roles: </span> Writing  Original Draft Preparation, Writing  Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-134/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 01 Feb 2018, 7:134 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.12787.1">https://doi.org/10.12688/f1000research.12787.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2018 Smith TJ. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=13855 data-id=12787 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12787.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-134/v1/pdf?article_uuid=9ac31451-8cf3-4ca4-b57b-8901518f8c6e" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.12787.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Smith TJ. New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):134 (<a href="https://doi.org/10.12688/f1000research.12787.1" target=_blank>https://doi.org/10.12688/f1000research.12787.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=12787 id=mobile-track-article-signin-12787 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12787?target=/articles/7-134"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13855 /> <input name=articleId type=hidden value=12787 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Jack Wall</strong>, Department of Medicine, Nepean Clinical School, Nepean Hospital, The University of Sydney, Australia </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Willem Dik</strong>, Department of Immunology, Laboratory Medical Immunology, Erasmus MC, The Netherlands </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 01 Feb 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-134&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-134&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=30198-30447></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=30197-30446></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-134/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>01 Feb 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Jack Wall</strong>, Department of Medicine, Nepean Clinical School, Nepean Hospital, The University of Sydney, Australia </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Willem Dik</strong>, Department of Immunology, Laboratory Medical Immunology, Erasmus MC, The Netherlands </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-134&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-134/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "New advances in understanding thyroid-associated...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-134/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-134/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-134/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Smith TJ');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-134/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-134",
            templates : {
                twitter : "New advances in understanding thyroid-associated ophthalmopathy.... Smith TJ, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-134/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/12787/13855")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "13855");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "30446": 0,
                           "30447": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "70662394-e1a3-4403-89af-d934017cbf3c";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-134.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-134.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-134.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-134.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-134.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>